Michael Altermatt

Neuroscientist @IOB | PhD in Neurobiology @Caltech

[Botond Roska @IOB_Roska]

Our work on #MitoCatch, a system for targeted delivery of healthy mitochondria to specific cell types is now published in @Nature.
Very grateful to the team and collaborators, especially the first authors, @AyupovTemurkhan, @v_moreno_juan.

📄 Read more: https://t.co/nTtYSejaEM

[Temurkhan Ayupov @AyupovTemurkhan]

Excited to share that our technology for cell-type-targeted mitochondrial delivery is published in @Nature.
In this work, we introduce MitoCatch, a platform that enables programmable, targeted delivery of donor mitochondria to specific cell types. (1/7)
https://t.co/5KcNqwDRkD

[Kika @v_moreno_juan]

I am very happy to share that our paper is now published in @Nature 😊
Cell-type-targeted mitochondrial transplantation rescues cell degeneration.
https://t.co/lQACEJLDwg
@IOB_ch (1/6)

[Stefan Spirig @StefanESpirig]

🎉 Thrilled to share our latest preprint! We conducted a large-scale screen with ~20,000 human retinal organoids, testing 2,707 compounds to counter cone-degeneration. Thanks to @IOB_Roska and my collaborators. 🧵👇 https://t.co/6yc7rkfaWT

[Michael Altermatt @AltermattMi]

@anat_kahan Wow, congrats Anat!🎉

[Michael Altermatt @AltermattMi]

@Kika_MJ @GLB_Lab @NeurosciIBRO Congratulations!🎉

[Michael Altermatt @AltermattMi]

@AlvaroHerrero1 @NeurocienciaUGR @UniversidadMH @NeuroAlc @GLB_Lab Wow, congratulations!

[Michael Altermatt @AltermattMi]

@jwjach Wow, congratulations Joanna!🎉

[Michael Altermatt @AltermattMi]

@xinhong_chen You made it! Congrats!

[Michael Altermatt @AltermattMi]

@VivianGradinaru @aaas @kkariko Congratulations Viviana!

[dibidave @dibidave]

I just realized I never tweeted the release of the main paper behind my PhD work 😅, where @AltermattMi, @cosmotat, and I developed a method to characterize which cells get targeted by AAV gene therapy vectors. So, a few months behind, here it is: https://t.co/iWC8Knc1oZ 1/6

[Michael Altermatt @AltermattMi]

@ryanjhcho Thank you Ryan!

[Michael Altermatt @AltermattMi]

The preprint of my third PhD research project is now available:

Deep parallel characterization of AAV tropism and AAV-mediated transcriptional changes via single-cell RNA sequencing https://t.co/gbBiRrZFYm

[Capsida Biotherapeutics @CapsidaBio]

We are hiring! Looking for talented people to join our fast-growing team as we work to create a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications. Visit https://t.co/Hy33O5iTZd

[Michael Altermatt @AltermattMi]

Thrilled to read in today’s biotech news that former coworkers successfully secured Series A financing for their startup. Congrats Capsida!

[FierceBiotech @FierceBiotech]

With a stealth launch comes Capsida Biotherapeutics Inc., though there’s nothing under-the-radar about its hefty financing https://t.co/5EZO9m8JcO

[Rava Azeredo da Silveira @Rava_daSilveira]

Applications welcome for a PhD position at the interface of neuroscience and machine learning, in Switzerland. https://t.co/69ya5GpbfC

[Addgene @Addgene]

iSeroSnFR is a new fluorescent reporter for serotonin from @LinTianLab that allow the optical detection of millisecond-scale serotonin transients.
https://t.co/RCYiSeK3QP

[Liz Unger, PhD @ElizabethKUnger]

Now available from @Addgene !

[Michael Altermatt @AltermattMi]

@ElizabethKUnger @VivianGradinaru @LinTianLab @CaltechN Thank you for the congratulations and an amazing collaboration!

[Lin Tian, PhD @LinTianPhD]

Here we used machine learning to guide directed evolution to design and radically change the ligand binding pocket for sensor engineering. Excellent team work with @LoogerL, @VivianGradinaru, @superkash, @vyy_sf! (1 of 2)

https://t.co/nl4DKrhWZT